GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 827 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $208,000 | +0.5% | 4,769 | +0.5% | 0.01% | 0.0% |
| Q1 2022 | $207,000 | -6.3% | 4,743 | -5.5% | 0.01% | 0.0% |
| Q4 2021 | $221,000 | +30.0% | 5,020 | +5.1% | 0.01% | +8.3% |
| Q1 2021 | $170,000 | +132.9% | 4,775 | +147.7% | 0.01% | +9.1% |
| Q1 2020 | $73,000 | -64.7% | 1,928 | -56.3% | 0.01% | -57.7% |
| Q4 2019 | $207,000 | +18.3% | 4,416 | +7.7% | 0.03% | +4.0% |
| Q3 2019 | $175,000 | -3.8% | 4,099 | -9.6% | 0.02% | -13.8% |
| Q2 2019 | $182,000 | +9.6% | 4,536 | +14.1% | 0.03% | +3.6% |
| Q1 2019 | $166,000 | +7.8% | 3,976 | -1.1% | 0.03% | -6.7% |
| Q4 2018 | $154,000 | +2.0% | 4,020 | +6.6% | 0.03% | +7.1% |
| Q3 2018 | $151,000 | -5.6% | 3,771 | -5.3% | 0.03% | -9.7% |
| Q2 2018 | $160,000 | +15.1% | 3,981 | +11.5% | 0.03% | 0.0% |
| Q1 2018 | $139,000 | +98.6% | 3,570 | +80.8% | 0.03% | +72.2% |
| Q4 2017 | $70,000 | -51.0% | 1,975 | -43.9% | 0.02% | -57.1% |
| Q3 2017 | $143,000 | +1942.9% | 3,520 | +1982.8% | 0.04% | +1300.0% |
| Q2 2017 | $7,000 | – | 169 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chubb Ltd | 400,000 | $15,404,000 | 6.76% |
| KAHN BROTHERS GROUP INC | 833,315 | $32,090,960,000 | 5.42% |
| Sio Capital Management, LLC | 180,811 | $6,963,000 | 4.06% |
| Sio Capital Management, LLC | 170,000 | $6,547,000 | 3.82% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,124,462 | $43,304,000 | 3.12% |
| Keystone Financial Planning, Inc. | 120,705 | $4,648,000 | 3.04% |
| PVG Asset Management | 186,553 | $7,184,156,000 | 3.02% |
| P.R. Herzig & Co. Inc. | 37,950 | $1,461,000 | 2.98% |
| EQUITY INVESTMENT CORP | 2,329,469 | $89,708,000 | 2.89% |
| Sterneck Capital Management, LLC | 114,816 | $4,422,000 | 2.84% |